Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Harrington

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Nature Communications|May 24, 2017
Complementary information derived from CRISPR Cas9 mediated gene deletion and suppressionJoseph Rosenbluh, Han Xu, William Harrington, et al.
Current Opinion in Oncology|September 1, 2007
AIDS related malignancies in BrazilJulio Sampaio, Carlos Brites, Iguaracyra Araujo, et al.
International Journal of Cancer|July 28, 2011
Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignanciesJuan-Carlos Ramos, Sang-Hoon Sin, Michelle R Staudt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2010
Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypesAli Bazarbachi, Yves Plumelle, Juan Carlos Ramos, et al.
Blood|February 4, 2010
Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID micePrabal Banerjee, Adam Tripp, Michael D Lairmore, et al.
Plos One|February 11, 2009
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphomaLee Ratner, William Harrington, Xuan Feng, et al.
Addiction Science & Clinical Practice|March 8, 2022
Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdownJacqueline Hodges, Marika Waselewski, William Harrington, et al.
Cancer|July 13, 2002
Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcomaAnil Tulpule, Jerome Groopman, M Wayne Saville, et al.
JMIR Formative Research|February 23, 2021
A Mobile Health App to Support Patients Receiving Medication-Assisted Treatment for Opioid Use Disorder: Development and Feasibility StudyMarika Elise Waselewski, Tabor Elisabeth Flickinger, Chelsea Canan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meetingKunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Nature Communications|May 24, 2017
Complementary information derived from CRISPR Cas9 mediated gene deletion and suppressionJoseph Rosenbluh, Han Xu, William Harrington, et al.
Current Opinion in Oncology|September 1, 2007
AIDS related malignancies in BrazilJulio Sampaio, Carlos Brites, Iguaracyra Araujo, et al.
International Journal of Cancer|July 28, 2011
Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignanciesJuan-Carlos Ramos, Sang-Hoon Sin, Michelle R Staudt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2010
Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypesAli Bazarbachi, Yves Plumelle, Juan Carlos Ramos, et al.
Blood|February 4, 2010
Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID micePrabal Banerjee, Adam Tripp, Michael D Lairmore, et al.
Plos One|February 11, 2009
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphomaLee Ratner, William Harrington, Xuan Feng, et al.
Addiction Science & Clinical Practice|March 8, 2022
Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdownJacqueline Hodges, Marika Waselewski, William Harrington, et al.
Cancer|July 13, 2002
Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcomaAnil Tulpule, Jerome Groopman, M Wayne Saville, et al.
JMIR Formative Research|February 23, 2021
A Mobile Health App to Support Patients Receiving Medication-Assisted Treatment for Opioid Use Disorder: Development and Feasibility StudyMarika Elise Waselewski, Tabor Elisabeth Flickinger, Chelsea Canan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meetingKunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi, et al.
Pageof 3